초록

Cancer is the leading cause of death worldwide and the most important cause of death in Korea. Many researches have been conducted for developing effective and safe anti-cancer drugs worldwide. Korean government recently declared to make traditional herbal medicine globally recognized and began to invest not a small budget for developing new promising herbal anti-cancer drugs. The pur- pose of this study is to investigate the scientific evidence of current Korean herbal medicines to be able to enter the world market through the studies of NEXIA. NEXIA (Rhus verniciflua Stokes), anti- cancer drug from traditional herbal medicine in Korea, has been used by Korean medicine physician legally without Ministry of Drug and Food Safety’s formal approval through a new drug approval system. We have found the studies on the NEXIA have not enough scientific evidence on safety and effectiveness due to lack of internal validity of the studies. In order to make our traditional herbal an- ti-cancer drugs successfully enter the world market, we have to establish effective system for evaluat- ing them through the world-widely recognized system such as clinical trial system of cancer drugs run by the U.S Food and Drug Administration. It should be prerequisite to establish sound evaluation system for safety and effectiveness of Korean herbal anti-cancer drugs for developing globally accept- able Korean herbal anti-cancer drugs.

키워드

Korean traditional anti-cancer drug · Cancer clinical trials · Globalization · NEXIA.

참고문헌(46)open

  1. [학술지] Global Burden of Disease Cancer Collaboration / 2015 / The Global Burden of Cancer 2013 / JAMA Oncol 1 : 505 ~ 527

  2. [인터넷자료] Statistics Korea / Cancer Registration Statistics

  3. [인터넷자료] Herper M / The Cancer Drug Market Just Hit $100 Billion And Could Jump 50% In Four Years

  4. [학술지] Hay M / 2014 / Clinical development success rates for investigational drugs / Nat Biotechnol 32 : 40 ~ 51

  5. [인터넷자료] 식약처 / 식약처, ‘15년 임상시험 승인현황 및 정기점검 결과 발표

  6. [기타] 민정혜 / 2015 / 넥시아 논란 10년에 식약처·복지부도 ‘답답’ / Dailymedi

  7. [기타] 송성철 / 2016 / 넥시아 검증 나섰다 고소 당한 환자단체 대표 “무혐의” / DoctorsNews

  8. [기타] 송수연 / 2016 / 2년 넘는 법정 다툼 드디어 끝낸 한정호 교수 / 청년의사

  9. [기타] 이석영 / 2016 / 의편협 “넥시아 논문은 중복출판에 해당” / DoctorsNews

  10. [기타] 송수연 / 2016 / [단독] 단국대 결국 ‘넥시아’ 버렸다…융합의료센터 문닫아 / 청년의사

  11. [학술지] Tagliaferri MA / 2013 / A phase IIb trial of coix seed injection for advanced pancreatic cancer / J Clin Oncol 31 : e15023

  12. [기타] Song M / 2015 / TCM approved by FDA to go further clinical trials / Xinhua News

  13. [학술지] Shaw D / 2012 / Pharmacovigilance of herbal medicine / J Ethnopharmacol 140 : 513 ~ 518

  14. [학술지] Lee SH / 2009 / Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience / Integr Cancer Ther 8 : 148 ~ 152

  15. [학술지] Lee SH / 2009 / Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized rhus verniciflua stokes extract: a case study / Explore 5 : 242 ~ 244

  16. [학술지] Kim KS / 2010 / A case of recurred hepatocellular carcinoma refractory to doxorubicin after liver transplantation showing response to herbal medicine product, Rhus verniciflua Stokes extract / Integr Cancer Ther 9 : 100 ~ 104

  17. [학술지] Lee SH / 2010 / Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua Stokes extract / J Altern Complement Med 16 : 497 ~ 500

  18. [학술지] Cheon SH / 2011 / Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer / Forsch Komplementmed 18 : 77 ~ 83

  19. [학술지] Lee S / 2011 / Efficacy and safety of standardized allergen-removed Rhus verniciflua Stokes extract in patients with advanced or metastatic pancreatic cancer: a Korean single-center experience / Oncology 81 : 312 ~ 318

  20. [학술지] Choi W / 2013 / Impact of standardized allergen-removed rhus verniciflua stokes extract on advanced adenocarcinoma of the ampulla of vater: a case series / Evid Based Complement Alternat Med 2013 : 203168

  21. [학술지] Lee J / 2013 / The efficacy and safety of standardized allergen-removed Rhus verniciflua extract as maintenance therapy after first-line chemotherapy in patients with advanced non-small cell lung cancer / Am J Chin Med 41 : 773 ~ 787

  22. [학술지] Delgado-Rodríguez M / 2004 / Bias / J Epidemiol Community Health 58 : 635 ~ 641

  23. [학술지] Greenhalgh T / 1997 / How to read a paper. Getting your bearings (deciding what the paper is about) / BMJ 315 : 243 ~ 246

  24. [인터넷자료] Canadian Cancer Society / Phases of clinical trials

  25. [인터넷자료] American Cancer Society / The Basics of Clinical Trials

  26. [학술지] Ananthakrishnan R / 2013 / Design of oncology clinical trials: a review / Crit Rev Oncol Hematol 88 : 144 ~ 153

  27. [학술지] Storer BE / 1989 / Design and analysis of phase I clinical trials / Biometrics 45 : 925 ~ 937

  28. [학술지] Le Tourneau C / 2009 / Dose escalation methods in phase I cancer clinical trials / J Natl Cancer Inst 101 : 708 ~ 720

  29. [학술지] Cabrera JR / 2017 / Phase I cancer clinical trials / Neuro-Oncol Pract 4 : 67 ~ 72

  30. [학술지] Jardim DL / 2014 / Predictive value of phase I trials for safety in later trials and final approved dose: analysis of 61 approved cancer drugs / Clin Cancer Res 20 : 281 ~ 288

  31. [학술지] Jung SH / 2014 / Randomized phase II clinical trials / J Biopharm Stat 24 : 802 ~ 816

  32. [학술지] Schlesselman JJ / 2006 / Phase II clinical trials in oncology: strengths and limitations of two-stage designs / Cancer Invest 24 : 404 ~ 412

  33. [인터넷자료] American Society of Clinical Oncolgy / Placebos in Cancer Clinical Trials

  34. [학술지] Viale PH / 2008 / Postmarketing surveillance for oncology drugs / Clin J Oncol Nurs 12 : 877 ~ 886

  35. [학술지] Spigel DR / 2010 / The value of observational cohort studies for cancer drugs / Biotechnol Healthc 7 : 18 ~ 24

  36. [인터넷자료] American Society of Clinical Oncology / Drug Discovery and Development

  37. [학술지] Sullivan JW / 1990 / A pharmaceutical manufacturer’s perspective on reporting adverse drug experiences / Am J Hosp Pharm 47 : 1342 ~ 1345

  38. [인터넷자료] US Food and Drug Administration / Regulatory Procedures Manual-Chapter 7 Recall Procedures

  39. [인터넷자료] Dooren JC / Pfizer to Withdraw a Cancer Drug Mylotarg

  40. [학술지] Davidson NE / 2016 / AACR Cancer Progress Report 2016 / Clin Cancer Res 22 (19 Supplement) : S1 ~ S137

  41. [학술지] 정희정 / 2010 / 국내 한방병원의 IRB 및 임상시험 실태조사 / 대한한의학회지 31 (1) : 122 ~ 129

  42. [학술지] 김성준 / 2015 / 품질관리 규제의 합리적인 대안 탐색: 한약재 제조업소를 중심으로 / 한국사회와 행정연구 26 (3) : 255 ~ 278

  43. [기타] 송성철 / 2017 / 한약 부작용으로 신장이식…법원 “2억원 배상” / Doctors-News

  44. [인터넷자료] / WHO Collaborating Centre for Drug Statistics Methodology

  45. [인터넷자료] Daniells S / Herbal supplement sales to hit $93.15 billion by 2015: Report

  46. [인터넷자료] Global Industry Analysts, Inc. / The Global Herbal Supplements and Remedies Market Trends, Drivers & Projections